LeMaitre Vascular (LMAT) Competitors

LeMaitre Vascular (NASDAQ:LMAT) and Teleflex (NYSE:TFX) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, community ranking, earnings and risk.

Which has more risk & volatility, LMAT or TFX?

LeMaitre Vascular has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500.

Which has stronger earnings and valuation, LMAT or TFX?

Teleflex has higher revenue and earnings than LeMaitre Vascular. Teleflex is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$213.03M	9.60	$30.10M	$1.83	49.69
Teleflex	$2.97B	2.78	$356.33M	$5.03	35.44

Do institutionals and insiders hold more shares of LMAT or TFX?

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 10.8% of LeMaitre Vascular shares are held by insiders. Comparatively, 1.4% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Does the media refer more to LMAT or TFX?

In the previous week, LeMaitre Vascular had 1 more articles in the media than Teleflex. MarketBeat recorded 15 mentions for LeMaitre Vascular and 14 mentions for Teleflex. LeMaitre Vascular's average media sentiment score of 0.80 beat Teleflex's score of 0.80 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	6 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	5 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Is LMAT or TFX a better dividend stock?

LeMaitre Vascular pays an annual dividend of $0.64 per share and has a dividend yield of 0.7%. Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 0.8%. LeMaitre Vascular pays out 35.0% of its earnings in the form of a dividend. Teleflex pays out 27.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. LeMaitre Vascular has increased its dividend for 13 consecutive years. Teleflex is clearly the better dividend stock, given its higher yield and lower payout ratio.

Do analysts rate LMAT or TFX?

LeMaitre Vascular presently has a consensus target price of $94.57, suggesting a potential upside of 4.00%. Teleflex has a consensus target price of $259.00, suggesting a potential upside of 45.28%. Given Teleflex's higher probable upside, analysts clearly believe Teleflex is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.89
Teleflex	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.63

Is LMAT or TFX more profitable?

LeMaitre Vascular has a net margin of 19.40% compared to Teleflex's net margin of 7.85%. Teleflex's return on equity of 14.19% beat LeMaitre Vascular's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	19.40%	13.15%	11.47%
Teleflex	7.85%	14.19%	8.53%

Does the MarketBeat Community favor LMAT or TFX?

Teleflex received 11 more outperform votes than LeMaitre Vascular when rated by MarketBeat users. However, 70.70% of users gave LeMaitre Vascular an outperform vote while only 59.26% of users gave Teleflex an outperform vote.

Company	Underperform	Outperform
LeMaitre Vascular	Outperform Votes 514 70.70%	Underperform Votes 213 29.30%
Teleflex	Outperform Votes 525 59.26%	Underperform Votes 361 40.74%

Summary

LeMaitre Vascular beats Teleflex on 12 of the 22 factors compared between the two stocks.